Adult acute leukemia studies utilizing cytarabine: Early southwest oncology group trials

Charles A. Coltman, Emil J. Freireich, Olga Pendleton, John N. Bickers, Gerald P. Bodey, James S. Hewlett, Kenneth B. McCredie

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Four Southwest Oncology Group clinical trials in adult acute leukemia were conducted between June 1967 and January 1975 involving 741 adult patients. The trials involved Cytarabine (ARA‐C) alone and in combination. The last patient started treatment over five years ago and 81 of 741 (11%) survived more than five years. The last death was at 9 ½ years with followup out to 13 ½ years.

Original languageEnglish (US)
Pages (from-to)173-183
Number of pages11
JournalMedical and Pediatric Oncology
Volume10
Issue number1 S
DOIs
StatePublished - 1982
Externally publishedYes

Keywords

  • 5 year survival
  • acute leukemia
  • combination chemotherapy
  • cytarabine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Adult acute leukemia studies utilizing cytarabine: Early southwest oncology group trials'. Together they form a unique fingerprint.

Cite this